Related Experiment Video
Updated: Jun 19, 2026

10:03
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
STUDIES ON MENINGOCOCCUS INFECTION : VI. THE CARRIER PROBLEM.
1Laboratories of The Rockefeller Institute for Medical Research.
The Journal of Experimental Medicine
|October 30, 2009
Summary
Chronic meningococcal carriers can harbor the same strain for over two years. Upper respiratory infections, particularly those with increased pathogens, can reduce meningococcal presence in carriers.
Area of Science:
- Microbiology
- Epidemiology
- Immunology
Background:
- The Rockefeller Institute group study provides insights into meningococcal carrier states.
- Understanding carrier dynamics is crucial for controlling meningococcal disease transmission.
Purpose of the Study:
- To categorize meningococcal carriers and investigate factors influencing carrier persistence.
- To characterize meningococcal strains isolated from carriers and compare them to clinical isolates.
Main Methods:
- Analysis of carrier states in 24 individuals from the Rockefeller Institute group.
- Isolation and characterization of 26 meningococcal strains from carriers.
- Serological testing, including absorption tests, to determine strain relationships.
- Investigation of the impact of upper respiratory infections (coryza, pharyngitis) on meningococcal carriage.
Main Results:
- Three carrier types identified: chronic (over 2 years), intermittent, and transient.
- Half of the carriers were chronic, persistently harboring the same strain.
- Spontaneous "cures" can be temporary, with strains reappearing after months.
- Coryza alone did not alter meningococcal levels, but streptococcal pharyngitis reduced them.
- Eight of 26 carrier strains matched Gordon's types; 18 were considered true meningococci.
- Serological analysis revealed strains belonged to broad serological Groups I and II.
- Atypical Type II* strains from carriers caused cerebrospinal fever.
- Group II strains predominated in carriers during interepidemic periods, while Group I strains were more common during epidemics.
- Carrier strains showed lower viability in defibrinated rabbit blood compared to meningitis strains.
Conclusions:
- Meningococcal carrier states can be long-lasting, with consistent strain carriage.
- Upper respiratory infections influence meningococcal carriage, with bacterial co-infections potentially reducing meningococcal load.
- Carrier strains exhibit diverse serological profiles, with implications for disease epidemiology.
- Further research is needed to understand the significance of reduced carrier strain viability and to conduct comparative virulence studies.
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...

